Camp4 Therapeutics Corp (CAMP)

$4.62 +0.17 (3.82%)
Market Cap 89.72M
Revenue (ttm) 294.95M
Net Income (ttm) -32.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.02%
Debt to Equity Ratio 0.00
Volume 22,300
Avg Vol 111,548
Day's Range N/A - N/A
Shares Out 20.16M
Stochastic %K 52%
Beta N/A
Analysts Strong Sell
Price Target $19.00

Latest News on CAMP

Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO

Sep 20, 2024, 3:35 PM EDT - 4 months ago

Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO

Kaiser Permanente-backed biopharma CAMP4 files for US IPO

Sep 20, 2024, 2:23 PM EDT - 4 months ago

Kaiser Permanente-backed biopharma CAMP4 files for US IPO

CAMP4 Therapeutics IPO Registration Document (S-1)

Sep 20, 2024, 1:35 PM EDT - 4 months ago

CAMP4 Therapeutics IPO Registration Document (S-1)

CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders

Sep 17, 2024, 8:00 AM EDT - 4 months ago

CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders